Showing results (171-180 of 227) with videos related to
Sort By:
Pageof 23
Human Molecular Genetics|June 7, 2013
Method for widespread microRNA-155 inhibition prolongs survival in ALS-model miceErica D Koval, Carey Shaner, Peter Zhang, et al.International Journal of Geriatric Psychiatry|September 21, 2016
Gray matter regions statistically mediating the cross-sectional association of eotaxin and set-shifting among older adults with major depressive disorderStephen F Smagula, Helmet T Karim, Eric J Lenze, et al.Acta Neuropathologica|October 6, 2016
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitisClaudia Cantoni, Francesca Cignarella, Laura Ghezzi, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2014
B cell antigen presentation in the initiation of follicular helper T cell and germinal center differentiationLisa G Barnett, Helen M A Simkins, Burton E Barnett, et al.Frontiers in Immunology|April 18, 2022
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II TrialsTjalf Ziemssen, Douglas L Arnold, Enrique Alvarez, et al.European Journal of Immunology|April 7, 2011
Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responsesGregory F Wu, Evann Corbo, Michelle Schmidt, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2022
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and IIJutta Gärtner, Stephen L Hauser, Amit Bar-Or, et al.Neurology and Therapy|March 14, 2022
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with OfatumumabAnne H Cross, Silvia Delgado, Mario Habek, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2013
Regulatory T cells suppress the late phase of the immune response in lymph nodes through P-selectin glycoprotein ligand-1Stefano Angiari, Barbara Rossi, Laura Piccio, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 27, 2013
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosisChiara Fenoglio, Elisa Ridolfi, Claudia Cantoni, et al.Pageof 23